Cytosorbents Corp
CTSO
CTSO
88 hedge funds and large institutions have $58.8M invested in Cytosorbents Corp in 2022 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 24 increasing their positions, 28 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
14% less repeat investments, than reductions
Existing positions increased: 24 | Existing positions reduced: 28
21% less capital invested
Capital invested by funds: $74.4M → $58.8M (-$15.6M)
Holders
88
Holding in Top 10
–
Calls
$71K
Puts
$3K
Top Buyers
| 1 | +$1.24M | |
| 2 | +$579K | |
| 3 | +$539K | |
| 4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$379K |
| 5 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
+$352K |
Top Sellers
| 1 | -$1.44M | |
| 2 | -$716K | |
| 3 | -$392K | |
| 4 |
Walleye Trading
New York
|
-$201K |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
-$169K |